As discussed in this review, the up-regulation of Nrf2 may favor tumor growth by reducing apoptosis and the relation between Nrf2 and cancer cells is contradictory, therefore, genetic interventions that increase Nrf2 activity may not be a suitable therapeutic approach for cancer. This evidence concerns the gene NFE2L2 and neoplasm.